In Vivo photodynamic characteristics of the near-infrared photosensitizer 5,10,15,20-tetrakis(M-hydroxyphenyl) bacteriochlorin

Photochemistry and Photobiology

Volumn 72, Issue 3, 2000, Pages 358-364

  Rovers, Jeroen P ^a,b   De Jode, Martin L ^a   Rezzoug, Hadjira ^a   Grahn, Michael F ^a,c  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5,10,15,20 TETRAKIS(3 HYDROXYPHENYL)BACTERIOCHLORIN; PHOTOSENSITIZING AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEACHING; CELL LINE; COLORECTAL TUMOR; CONTROLLED STUDY; LIGHT IRRADIANCE; LIVER; MALE; MOUSE; NONHUMAN; PHOTODYNAMICS; RAT; TISSUE NECROSIS;

ANIMALS; COLONIC NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; PHOTOSENSITIZING AGENTS; PORPHYRINS; RATS; RATS, WISTAR; SPECTROSCOPY, NEAR-INFRARED;

ANIMALIA;

EID: 0034286848     PISSN: 00318655     EISSN: None     Source Type: Journal    
DOI: 10.1562/0031-8655(2000)072<0358:IVPCOT>2.0.CO;2     Document Type: Article

References (33)

1. van Hillegersberg, R., J. P. Marijnissen, W. J. Kort, P. E. Zondervan, O. T. Terpstra and W. M. Star (1992) Interstitial photodynamic therapy in a rat liver metastasis model. Br. J. Cancer 66, 1005-1014.
2. Rovers, J. P., J. J. Schuitmaker, A. L. Vahrmeijer, J. H. van Dierendonck and O. T. Terpstra (1998) Interstitial photodynamic therapy with the second-generation photosensitizer bacteriochlorin a in a rat model for liver metastases. Br. J. Cancer 77, 2098-2103.
3. Wilson, B. C., W. P. Jeeves, D. M. Lowe and G. Adam (1984) Light propagation in animal tissues in the wavelength range of 375-825 nanometers. Porphyrin localization and treatment of tumors, pp. 115-132. Liss, New York.
4. Berenbaum, M. C., S. L. Akande, R. Bonnett, H. Kaur, S. Ioannou, R. D. White and U. J. Winfield (1986) meso-Tetra-(hydroxyphenyl)porphyrins, a new class of potent tumor photosensitisers with favourable selectivity. Br. J. Cancer 54, 717-725.
5. Bonnett, R., R. D. White, U. J. Winfield and M. C. Berenbaum (1989) Hydroporphyrins of the meso-tetra(hydroxyphenyl)porphyrin series as tumor photosensitizers. Biochemical Journal 261, 277-280.
6. Grahn, M. F., A. McGuinness, R. Benzie, R. Boyle, M. L. de Jode, M. G. Dilkes, B. Abbas and N. S. Williams (1997) Intracellular uptake, absorption spectrum and stability of the bacteriochlorin photosensitizer 5, 10, 15, 20-tetrakis(m-hydroxyphenyl)bacteriochlorin (mTHPBC) Comparison with 5, 10, 15, 20-tetrakis(m-hydroxyphenyl)chlorin (mTHPC) J. Photochem. Photobiol. B Biol. 37, 261-266.
7. Bonnett, R., P. Charlesworth, B. D. Djelal, S. Foley, D. J. McGarvey and T. G. Truscott (1999) Photophysical properties of 5, 10, 15, 20-tetrakis(m-hydroxyphenyl)porphyrin (m-THPP), 5, 10, 15, 20-tetrakis(m-hydroxyphenyl)chlorin (m-THPC) and 5, 10, 15, 20-tetrakis(m-hydroxyphenyl)bacteriochlorin (m-THPBC): a comparative study. J. Chem. Soc. Perkin Trans. 2, 325-328.
8. Rovers, J. P., M. L. de Jode and M. F. Grahn (2000) Significantly increased laser light-induced damage using the near-infra red photosensitizer 5, 10, 15, 20-tetrakis(m-hydroxyphenyl) bacteriochlorin in interstitial photodynamic therapy of normal rat liver tissue. Lasers Surg. Med. (In press).
9. Star, W. M (1995) In vivo action spectra, absorption and fluorescence excitation spectra of photosensitizers for photodynamic therapy. J. Photochem. Photobiol. B Biol. 28, 101-102.
10. Anderson, V. C. and D. H. Thompson (1992) Triggered release of hydrophilic agents from plasmalogen liposomes using visible light or acid. Biochim. Biophys. Acta 1109, 33-42.
11. Bonnett, R., B. D. Djelal, P. A. Hamilton, G. Martinez and F. Wierrani (1999) Photobleaching of 5,10,15,20-tetrakis(m-hydroxyphenyl)porphyrin (mTHPP) and the corresponding chlorin (mTHPC) and bacteriochlorin (mTHPBC) A comparitive study. J. Photochem. Photobiol. B Biol. 53, 136-143.
12. Ansell, J. K., M. L. de Jode and M. F. Grahn (1997) Characterisation of a routine model for the rapid assessment of the acute photodynamic response in tumor and muscle. Lasers Med. Sci. 12, 336-341.
13. de Jode, M. L., J. A. McGilligan, M. G. Dilkes, I. Cameron, M. F. Grahn and N. S. Williams (1996) An in vivo comparison of the photodynamic action of a new diode laser and a copper vapour dye laser at 652 nm. Lasers Med. Sci. 11, 117-121.
14. Grahn, M. F., M. L. de Jode, M. L. Dilkes, J. K. Ansell, D. Onwu, J. Maudsley and N. S. Williams (1997) Tissue photosensitizer detection by low-power remittance fluorimetry. Lasers Med. Sci. 12, 245-252.
15. Rovers, J. P., A. E. Saarnak, A. Molina, J. J. Schuitmaker, H. J. C. M. Sterenborg and O. T. Terpstra (1999) Effective treatment of liver metastases with photodynamic therapy, using the second generation photosensitizer meta-tetra(hydroxyphenyl)-chlorin (mTHPC), in a rat model. Br. J. Cancer 81, 600-608.
16. Wilson, B. C., M. S. Patterson and D. M. Burns (1986) Effect of photosensitizer concentration in tissue on the penetration depth of photoactivating light. Lasers Med. Sci. 1, 235-244.
17. van Gemert, J. C., M. C. Berenbaum and G. H. M. Gijsberg (1985) Wavelength and light-dose dependence in tumor phototherapy with hematoporphyrin derivative. Br. J. Cancer 52, 43-49.
18. Bown, S. G., C. J. Tralau, P. D. Smith, D. Akdemir and T. J. Wieman (1986) Photodynamic therapy with porphyrin and phthalocyanine sensitisation: quantitative studies in normal rat liver. Br. J. Cancer 54, 43-52.
19. Gibson, S. L. and S. Hilf (1985) Interdependence of fluence, drug dose and oxygen on hematoporphyrin derivative induced photosensitization of tumor mitochondria. Photochem. Photobiol. 42, 367-373.
20. Cowled, P. A. and I. J. Forbes (1985) Photocytotoxicity in vivo of hematoporphyrin derivative components. Cancer Lett. 28, 111-118.
21. Fingar, V. H., W. R. Potter and B. W. Henderson (1987) Drug and light dose dependence of photodynamic therapy: a study of tumor cell clonogenicity and histologic changes. Photochem. Photobiol. 45, 643-650.
22. Messmann, H., P. Mlkvy, G. Buonaccorsi, C. L. Davies, A. J. MacRobert and S. G. Bown (1995) Enhancement of photodynamic therapy with 5-aminolaevulinic acid-induced porphyrin photosensitisation in normal rat colon by threshold and light fractionation studies. Br. J. Cancer 72, 589-594.
23. van Geel, I. P., H. Oppelaar, J. P. Marijnissen and F. A. Stewart (1996) Influence of fractionation and fluence rate in photodynamic therapy with Photofrin or mTHPC. Radiat. Res. 145, 602-609.
24. Rezzoug, H., O. Bezdetnaya, O. A'Amar, F. Merlin and F. Guillemin (1998) Influence of different parameters on photodynamic activity of meso-tetra(m-hydroxyphenyl)chlorin (m-THPC): in vitro and in vivo. Lasers Med. Sci. 13, 119-125.
25. Foster, T. H., R. S. Murant, R. G. Bryant, R. S. Knox, S. L. Gibson and R. Hilf (1991) Oxygen consumption and diffusion effects in photodynamic therapy. Radiation Research 126, 296-303.
26. Gomer, C. J., N. Rucker, N. J. Razum and A. L. Murphree (1985) In vitro and in vivo light dose rate effects related to hematoporphyrin derivative photodynamic therapy. Cancer Res. 45, 1973-1977.
27. Chen, Q., M. Chopp, M. O. Dereski, B. C. Wilson, M. S. Patterson, A. Schreiber and F. W. Hetzel (1992) The effect of light fluence rate in photodynamic therapy of normal rat brain. Radiation Research 132, 120-123.
28. Tromberg, B. J., A. Orenstein, S. Kimel, S. J. Barker, J. Hyatt, J. S. Nelson and M. W. Berns (1990) In vivo tumor oxygen tension measurements for the evaluation of the efficiency of photodynamic therapy. Photochem. Photobiol. 52, 375-385.
29. Sitnik, T. M. and B. W. Henderson (1996) The effect of fluence rate on tumor and normal tissue responses to photodynamic therapy. Photochem. Photobiol. 67, 462-466.
30. Andrejevic-Blant, S., A. Woodtli, G. Wagnieres, C. Fontolliet, H. van den Bergh and P. Monnier (1996) In vivo fluence rate effect in photodynamic therapy of early cancers with tetra(m-hydroxyphenyl)chlorin. Photochem. Photobiol. 64, 963-968.
31. Stewart, F. A. and Y. Oussoren (1993) Functional and histological bladder damage in mice after photodynamic therapy: the influence of sensitiser dose and time of administration. Br. J. Cancer 68, 673-677.
32. van den Boogert, J., R. van Hillegersberg, H. J. van Staveren, R. W. F. de Bruin, H. van Dekken, P. D. Siersema and H. W. Tilanus (1999) Timing of illumination is essential for effective and safe photodynamic therapy: a study in the normal rat oesophagus. Br. J. Cancer 79, 825-830.
33. Rovers, J. P., A. E. Saarnak, M. de Jode, H. J. C. M. Sterenborg, O. T. Terpstra and M. F. Grahn (2000) Biodistribution and bioactivity of tetra-pegylated meta-tetra(hydroxyphenyl)chlorin compared to native meta-tetra(hydroxyphenyl)chlorin in a rat liver tumor model. Photochem. Photobiol. 77, 210-217.